Revefenacin
Specifications
864750-70-9CAS Number
811-471-4EC Number
[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamateIUPAC Name
C35H43N5O4Chemical Formula
597.7 g/molMolecular Weight
Revefenacin; 864750-70-9; TD-4208; Yupelri; GSK-1160724; revefenacina; revefenacine; GSK1160724; G2AE2VE07O; 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate; DTXSID701027775; [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate; Biphenyl-2-ylcarbamic acid, 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester; 1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1'-biphenyl]-2-ylcarbamate; revefenacinum; (1-(2-((4-((4-carbamoylpiperidin-1-yl)methyl)benzoyl)-methylamino)ethyl)piperidin-4-yl) N-(2-phenylphenyl)carbamate; 1-(2-((4-((4-(Aminocarbonyl)-1-piperidinyl)methyl)benzoyl)methylamino)ethyl)-4-piperidinyl N-(1,1'-biphenyl)-2-ylcarbamate; 1-(2-(1-(4-((4-carbamoylpiperidin-1-yl)methyl)phenyl)-N-methylformamido)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate; 1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate; RefChem:57759; R03BB08; DTXCID801513351; Revefenacin [INN]; Revefenacin [WHO-DD]; 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate; Biphenyl-2-ylcarbamic acid 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester; Carbamic acid, N-(1,1'-biphenyl)-2-yl-, 1-(2-((4-((4-(aminocarbonyl)-1-piperidinyl)methyl)benzoyl)methylamino)ethyl)-4-piperidinyl ester; TD-4208; GSK-1160724;[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate; Biphenyl-2-ylcarbamic Acid 1-(2-{[4-(4-Carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl Ester; Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester; Carbamic acid, [1,1'-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-; Yupelri (TN); 864750-70-9 (free base); MFCD28386316; Revefenacin (Standard); REVEFENACIN [MI]; Revefenacin (USAN/INN); Revefenacin [USAN:INN]; REVEFENACIN [USAN]; UNII-G2AE2VE07O; Revefenacin;GSK1160724; SCHEMBL356480; orb1223819; orb1299860; CHEMBL3833319; GTPL10129; REVEFENACIN [ORANGE BOOK]; C35H43N5O4; GLXC-23321; HMS3886K17; HMS5084F21; Revefenacin [USAN:INN:WHO-DD]; EX-A1722; EBC-27368; HY-15851R; s5258; TD4208; AKOS037649398; CCG-270187; CS-7743; DB11855; SB17262; NCGC00531543-01; BS-18189; DA-57407; FR178690; HY-15851; SY235747; TD-4208?; NS00073361; T7392; D10978; EN300-20352165; F797084; Q27278649; [1-[2-[[4-[(4-carbamoyl-1-piperidyl)methyl]benzoyl]-methyl-amino]ethyl]-4-piperidyl] N-(2-phenylphenyl)carbamate; 1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1 inverted exclamation marka-biphenyl]-2-ylcarbamate; 1-[2-[4-[(4-Carbamoyl-1-piperidinyl)methyl]-N-methylbenzamido]ethyl]-4-piperidinyl 2-Biphenylylcarbamate; 1211931-83-7; TD-4208;1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1-biphenyl]-2-ylcarbamateSynonyms
No companies, products, or articles found for this substance yet.